danazol has been researched along with Atherogenesis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cervenak, L; Farkas, H; Kajdácsi, E; Karádi, I; Kőhalmi, KV; Nebenführer, Z; Szabó, E; Zsáry, A | 1 |
Birjmohun, RS; Dallinga-Thie, GM; Hofstra, JJ; Kastelein, JJ; Kees Hovingh, G; Levi, M; Meijers, JC; Stroes, ES | 1 |
1 trial(s) available for danazol and Atherogenesis
Article | Year |
---|---|
Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
Topics: Adult; Angioedemas, Hereditary; Apolipoprotein A-I; Atherosclerosis; Blood Coagulation; Carotid Arteries; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cross-Over Studies; Cross-Sectional Studies; Danazol; Disease Progression; Female; Humans; Lipoproteins; Male; Middle Aged; Surveys and Questionnaires; Testosterone Congeners; Time Factors; Triglycerides; Tunica Intima | 2008 |
1 other study(ies) available for danazol and Atherogenesis
Article | Year |
---|---|
Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency.
Topics: Adult; Atherosclerosis; Bradykinin; Case-Control Studies; Complement C1 Inhibitor Protein; Danazol; Disease Progression; Endothelial Cells; Endothelium, Vascular; Estrogen Antagonists; Female; Hereditary Angioedema Types I and II; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Surveys and Questionnaires; Vasodilation; Young Adult | 2019 |